Vertex Pharmaceuticals Incorporated (VRTX)

Last Closing Price: 441.30 (2025-06-27)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Vertex Pharmaceuticals Incorporated (VRTX) had Net Income of $-535.60M for the most recently reported fiscal year, ending 2024-12-31.

Figures for fiscal year ending 2024-12-31
Income Statement Financials
$11.02B
Net Income
$-535.60M
$1.53B
$9.49B
$11.25B
$-232.90M
$481.40M
$248.50M
$248.50M
$-535.60M
$-535.60M
$-535.60M
$-535.60M
$-232.90M
$-25.70M
257.90M
257.90M
$-2.08
$-2.08
Balance Sheet Financials
$9.60B
$1.23B
$12.94B
$22.53B
$3.56B
$112.80M
$2.56B
$6.12B
$16.41B
$14.50B
$16.41B
256.94M
Cash Flow Statement Financials
$-492.60M
$-3.77B
$-1.49B
$10.37B
$4.57B
$-5.80B
$698.50M
--
--
Fundamental Metrics & Ratios
2.69
--
--
0.01
0.01
86.11%
-2.11%
-2.11%
-0.23%
2.25%
-4.86%
$-790.30M
--
--
--
0.49
1.27
6.85
53.31
-3.26%
-3.69%
-2.38%
-3.24%
$63.87
$-3.06
$-1.91